Let's Get Real about Molecular Breast Imaging and Radiation Risk.
作者信息
Hruska Carrie B
机构信息
Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905.
出版信息
Radiol Imaging Cancer. 2019 Sep 27;1(1):e190070. doi: 10.1148/rycan.2019190070. eCollection 2019 Sep.
Abstract
摘要
相似文献
1
Let's Get Real about Molecular Breast Imaging and Radiation Risk.让我们正视分子乳腺成像与辐射风险。
Radiol Imaging Cancer. 2019 Sep 27;1(1):e190070. doi: 10.1148/rycan.2019190070. eCollection 2019 Sep.
2
Comparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breast.比较乳房摄影术和分子成像的辐射暴露及相关的辐射致癌风险。
Med Phys. 2010 Dec;37(12):6187-98. doi: 10.1118/1.3512759.
3
Comparative Benefit-to-Radiation Risk Ratio of Molecular Breast Imaging, Two-Dimensional Full-Field Digital Mammography with and without Tomosynthesis, and Synthetic Mammography with Tomosynthesis.分子乳腺成像、二维全视野数字化乳腺摄影与断层合成及合成乳腺断层摄影的辐射风险与获益比比较。
Radiol Imaging Cancer. 2019 Sep 27;1(1):e190005. doi: 10.1148/rycan.2019190005. eCollection 2019 Sep.
4
Overdiagnosis and Risks of Breast Cancer Screening.乳腺癌筛查的过度诊断与风险
Radiol Clin North Am. 2021 Jan;59(1):19-27. doi: 10.1016/j.rcl.2020.09.005.
5
Quantitative analysis of radiation dosage and image quality between digital breast tomosynthesis (DBT) with two-dimensional synthetic mammography and full-field digital mammography (FFDM).数字乳腺断层合成摄影（DBT）与全视野数字化乳腺摄影（FFDM）二维合成钼靶的辐射剂量和图像质量的定量分析。
Clin Imaging. 2019 May-Jun;55:12-17. doi: 10.1016/j.clinimag.2019.01.014. Epub 2019 Jan 17.
6
Leadership perspectives on key elements influencing implementing a family-focused intervention in mental health services.领导力视角下影响精神卫生服务中实施以家庭为中心干预的关键要素。
J Psychiatr Ment Health Nurs. 2020 Oct;27(5):616-627. doi: 10.1111/jpm.12615. Epub 2020 Feb 24.
7
Breast-iRRISC: a novel model for predicting the individualised lifetime risk of radiation-induced breast cancer from a single screening event.乳腺-iRRISC：一种基于单次筛查预测个体辐射诱发乳腺癌终生风险的新型模型。
Br J Radiol. 2021 Jan 1;94(1117):20200734. doi: 10.1259/bjr.20200734. Epub 2020 Oct 8.
8
[Is mammography screening efficient? Let's open the debate].
Epidemiol Prev. 2001 Nov-Dec;25(6):233-4.
9
Home is where recovery begins.家是康复的起点。
Behav Healthc. 2008 May;28(5):8, 13-5.
10
Continued capacity: Factors of importance for organizations to support continued Let's Talk practice - a mixed-methods study.持续能力：支持持续对话实践的重要因素——一项混合方法研究。
Int J Ment Health Nurs. 2020 Dec;29(6):1131-1143. doi: 10.1111/inm.12754. Epub 2020 Jun 28.
引用本文的文献
1
Current Concepts in Molecular Breast Imaging.分子乳腺成像的当前概念
J Breast Imaging. 2025 Jan 25;7(1):104-118. doi: 10.1093/jbi/wbae076.
2
Case report: Possible role of low-dose PEM for avoiding unneeded procedures associated with false-positive or equivocal breast MRI results.病例报告：低剂量钆双胺增强磁共振成像在避免与乳腺磁共振成像假阳性或不确定结果相关的不必要检查中的潜在作用
Front Oncol. 2024 Jul 18;14:1405404. doi: 10.3389/fonc.2024.1405404. eCollection 2024.
3
Breast Cancer Detection Using a Low-Dose Positron Emission Digital Mammography System.使用低剂量正电子发射数字乳腺摄影系统进行乳腺癌检测。
Radiol Imaging Cancer. 2024 Mar;6(2):e230020. doi: 10.1148/rycan.230020.
4
The Impact of Dense Breasts on the Stage of Breast Cancer at Diagnosis: A Review and Options for Supplemental Screening.致密型乳腺对乳腺癌诊断分期的影响：综述及补充筛查的选择。
Curr Oncol. 2022 May 17;29(5):3595-3636. doi: 10.3390/curroncol29050291.
5
Updates in Molecular Breast Imaging.分子乳腺成像的最新进展。
Semin Roentgenol. 2022 Apr;57(2):134-138. doi: 10.1053/j.ro.2021.12.006. Epub 2021 Dec 31.
6
Advances and Future Directions in Molecular Breast Imaging.分子乳腺成像的进展与未来方向。
J Nucl Med. 2022 Jan;63(1):17-21. doi: 10.2967/jnumed.121.261988. Epub 2021 Dec 9.
7
The Clinical Utility of a Negative Result at Molecular Breast Imaging: Initial Proof of Concept.分子乳腺影像阴性结果的临床实用性：初步概念验证。
Radiol Imaging Cancer. 2020 Sep 25;2(5):e190096. doi: 10.1148/rycan.2020190096. eCollection 2020 Sep.
本文引用的文献
1
Comparative Benefit-to-Radiation Risk Ratio of Molecular Breast Imaging, Two-Dimensional Full-Field Digital Mammography with and without Tomosynthesis, and Synthetic Mammography with Tomosynthesis.分子乳腺成像、二维全视野数字化乳腺摄影与断层合成及合成乳腺断层摄影的辐射风险与获益比比较。
Radiol Imaging Cancer. 2019 Sep 27;1(1):e190005. doi: 10.1148/rycan.2019190005. eCollection 2019 Sep.
2
Dose Reduction in Molecular Breast Imaging With a New Image-Processing Algorithm.应用新型图像处理算法降低分子乳腺成像剂量
AJR Am J Roentgenol. 2020 Jan;214(1):185-193. doi: 10.2214/AJR.19.21582. Epub 2019 Oct 8.
3
The BEIR VII Estimates of Low-Dose Radiation Health Risks Are Based on Faulty Assumptions and Data Analyses: A Call for Reassessment.《BEIR VII 估计低剂量辐射健康风险的依据是错误的假设和数据分析：呼吁重新评估》
J Nucl Med. 2018 Jul;59(7):1017-1019. doi: 10.2967/jnumed.117.206219. Epub 2018 Feb 23.
4
ACR Appropriateness Criteria Breast Cancer Screening.美国放射学会（ACR）乳腺癌筛查适宜性标准
J Am Coll Radiol. 2017 Nov;14(11S):S383-S390. doi: 10.1016/j.jacr.2017.08.044.
5
Molecular Breast Imaging for Screening in Dense Breasts: State of the Art and Future Directions.用于致密乳腺筛查的分子乳腺成像：现状与未来方向
AJR Am J Roentgenol. 2017 Feb;208(2):275-283. doi: 10.2214/AJR.16.17131. Epub 2016 Oct 20.
6
Benefit to Radiation Risk of Breast-specific Gamma Imaging Compared with Mammography in Screening Asymptomatic Women with Dense Breasts.乳腺特异性伽玛成像筛查致密乳腺无症状女性与乳腺钼靶相比的辐射风险获益。
Radiology. 2016 Nov;281(2):583-588. doi: 10.1148/radiol.2016151581. Epub 2016 Jun 3.
7
Curies, and Grays, and Sieverts, Oh My: A Guide for Discussing Radiation Dose and Risk of Molecular Breast Imaging.居里、戈瑞和希沃特，天哪：分子乳腺成像辐射剂量与风险讨论指南
J Am Coll Radiol. 2015 Oct;12(10):1103-5. doi: 10.1016/j.jacr.2015.07.001.
8
Diagnostic workup and costs of a single supplemental molecular breast imaging screen of mammographically dense breasts.乳腺钼靶致密型乳房单次补充性分子乳腺成像筛查的诊断检查及费用
AJR Am J Roentgenol. 2015 Jun;204(6):1345-53. doi: 10.2214/AJR.14.13306.
Zotero 插件